Home › Heart Attack › Georgia
Heart Attack clinical trials in Georgia
3 studies for Heart Attack are looking for participants at sites in Georgia.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Coastal Medical Research, LLC, Brunswick
- Renal Associates LLC, Columbus
- National Clinical Trials, Cordele
- and 2 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Emory University, Atlanta
- Cardiovascular Consultants of S GA, Thomasville
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Emory University Hospital, Atlanta
- East Coast Institute for Research, Canton
- Northeast Georgia Medical Center Wisteria Building, Cumming
- and 3 more
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.